HONG KONG, Sept. 26, 2025 /PRNewswire/ -- Himel, the globally acclaimed manufacturer and supplier of electrical products has successfully launched its "I Love Control" campaign across Bangladesh, Mongolia, South Africa, Malaysia, and Indonesia—marking a significant milestone in advancing its core "Powering Infinity" brand vision. Founded in Spain in 1958, Himel has expanded from its roots to serve over 60 countries, delivering reliable, affordable, and innovative electrical products. Its "Powering Infinity" vision embodies a commitment to long-term growth and empowering communities worldwide through smart energy solutions.
The "I Love Control" initiative, focused on industrial control and HVAC automation, has resonated strongly in each market. It showcases Himel's comprehensive portfolio—including AI-powered EBA (Energy Management & Building Automation) systems (delivering up to 30% energy savings), SP Series Variable Speed Drives (VSDs) with built-in pumping protection, globally top-ranked smart relay controllers, and the new X series contactor, overload relay, motor circuit breaker designed for flexible application across pumping, HVAC, conveyor systems, and machinery. All solutions are tailored to enhance efficiency in HVAC systems, industrial ventilation, pumping operations, and residential/commercial electrical setups. The initiative has received positive feedback from partners and customers, who highlight the portfolio's durability, safety, and alignment with local infrastructure development goals.
Koon San Ang, Himel's International Sales Vice President, noted: "Amid global political and economic instability, our 'I Love Control' campaign underscores our steadfastness—trusted channel partners and user-centric solutions drive our growth. By deepening partner collaboration, we're building an ecosystem that supports partners while meeting local communities' demands." Danny Wang, Himel's Chief Marketing Officer, added: "'I Love Control' is a core pillar of our 'Powering Infinity' brand vision. Under this vision, it showcases our product strength by empowering HVAC systems and partners with smart solutions. Each achievement in this initiative boosts our brand value, expands our global influence, and helps 'Powering Infinity' reach more regions—solidifying our role in driving industry efficiency and sustainability."
Himel is set to introduce the products and EBA solutions to Saudi Arabia and The United Arab Emirates in the coming months, further expanding its global presence and bringing its innovative and sustainable solutions to more communities worldwide.
To learn more about Himel's products and the "I Love Control" initiative, visit https://www.himel.com/gb.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Himel Elevates Global Presence with 'I Love Control' Initiative and Expands Power Infinity Vision Worldwide
Himel Elevates Global Presence with 'I Love Control' Initiative and Expands Power Infinity Vision Worldwide
PUNE, India, Aug. 4, 2026 /PRNewswire/ -- Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX™, a transformative end-to-end partnership model that enables governments, institutions, and biopharma organizations to establish world-class biomanufacturing capabilities wherever they need them.
Built on the company's proven EnzeneX® fully‑connected continuous manufacturing™ (FCCM™) platform, NeX delivers a turnkey, scalable, and sustainable way to make state-of-the-art innovation in biologics manufacturing transportable, close to patients and supply chains, and without the prohibitive capital burden of conventional fed‑batch facilities. By enabling local FCCM‑based manufacturing, governments can significantly expand patient affordability and access to life‑saving biologics.
Enzene's NeX program includes comprehensive build-out and launch coordination with support for facility design and build-out, technology transfer and IP licensing for the EnzeneX platform, workforce development through the company's SparX™ structured training curriculum, and ongoing operational support during start-up and commercialization. Where required, participating organizations may also receive access to selected products from Enzene's biosimilar portfolio for manufacture within their own regions.
"A conventional biologics plant often requires between $300 million and $400 million to build," commented Himanshu Gadgil, Ph.D., CEO of Enzene. "With our fully-connected continuous manufacturing platform, the same output can be achieved for $60–$80 million. The efficiency comes from a compact, integrated system architecture rather than the scale-intensive layouts of fed-batch facilities, allowing for long-term cost advantage and high product yields for locally manufactured biomedicines. We are already engaged in discussions with multiple governments and corporations all around the world and are looking forward to helping deliver affordable medicines to patients worldwide."
Enzene's NeX program is intended to help regions accelerate the establishment of local biopharma capabilities and risk-mitigated supply chains, develop domestic scientific talent, and reduce long-term manufacturing costs for local patients. The company estimates that facilities built under the program can achieve validation and commercial readiness in under three years.
For more information, visit www.enzene.com/nex.
About Enzene
Enzene is a Continuously Innovative Development and Manufacturing (CIDMO™) partner supporting innovators and biosimilar developers across discovery, development, and commercial supply. Operating from facilities in India and the U.S., Enzene provides integrated biologics development and manufacturing services enabled by its EnzeneX® fully‑connected continuous manufacturing™ (FCCM™) platform, which delivers the world's leading yields and cost efficiency, and is validated for commercial biologics production.
To expand regional biologics capability, Enzene also offers NeX™, an end‑to‑end partnership program that supports governments, institutions, and biopharma organizations in establishing local biomanufacturing, leveraging all the productivity, operating cost and capital advantages of continuous processing. NeX provides comprehensive facility design guidance, technology and IP transfer, workforce development through its SparX™ training program, operational oversight, and territory‑specific pipeline support.
For more information, visit www.enzene.com.
Media Contact:
Miles Fisher-Pollard
Orientation Marketing
milesfp@orientation.agency
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
